L. Hagmeyer

[Pharmacological treatment of idiopathic pulmonary fibrosis (update) and progressive pulmonary fibrosis - S2k Guideline of the German Respiratory Society].

H. Sitter, A. Prasse, M. Kreuter, 2023, Pneumologie.

Outcome differences between idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases (ILD) - data from the EXCITING registry

M. Kreuter, R. Leidl, P. Markart, 2018, Idiopathic interstitial pneumonias.

[Pharmacological treatment of idiopathic pulmonary fibrosis (update) and progressive pulmonary fibrosis - S2k Guideline of the German Respiratory Society].

H. Sitter, A. Prasse, M. Kreuter, 2023, Pneumologie.

SARS-CoV-2-Infektion und interstitielle Lungenerkrankungen – Positionspapier der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin

H. Woehrle, A. Prasse, F. Bonella, 2022, Pneumologie.

Investigating significant health trends in progressive fibrosing interstitial lung disease (INSIGHTS-ILD): rationale, aims and design of a nationwide prospective registry

A. Prasse, W. Gesierich, M. Kreuter, 2023, BMC Pulmonary Medicine.